Regenovue Sub Q with Lidocaine (1 x 1.1ml)

Regenovue

Aesthetic Injectable / Dermal Filler

Cross-linked hyaluronic acid dermal filler for deep wrinkles and volumisation

CE Marked hyaluronic acid dermal filler in applicable markets (classification subject to regional medical device regulations).
Manufactured under an ISO 13485 Compliant quality management system for medical devices.
Utilises highly purified, non Animal HA with low endotoxin and low residual BDDE within internationally accepted safety thresholds.

CE Marked hyaluronic acid dermal filler in applicable markets (classification subject to regional medical device regulations).
Manufactured under an ISO 13485 Compliant quality management system for medical devices.
Utilises highly purified, non Animal HA with low endotoxin and low residual BDDE within internationally accepted safety thresholds.

Cross-linked hyaluronic acid dermal filler for deep wrinkles and volumisation

Description

Regenovue Sub Q with Lidocaine (1 x 1.1ml) is the most viscous, high-density hyaluronic acid dermal filler in the Regenovue range, designed for deep wrinkles, severe folds and structural facial volumisation. Formulated with 24 mg/ml 100% cross-linked, non-animal hyaluronic acid and lidocaine for patient comfort, it provides strong lifting capacity and long-lasting volume. Its thick, monophasic gel is ideal for adding definition to cheeks and cheekbones, enhancing facial contours and improving the appearance of deep lines such as nasolabial folds and marionette lines. The filler is completely biodegradable and fully absorbed by the body over time, with effects typically lasting 8–12 months.

Bnefits

Most viscous and dense filler in the Regenovue line, providing strong volumising and lifting capacity for deep tissues.
Effectively adds volume to the face and restores or enhances contours (e.g. cheeks and cheekbones) for a healthier, more youthful appearance.
Reduces the appearance of deep wrinkles and severe folds, including nasolabial folds and marionette lines.
Longer-lasting results, typically 8–12 months depending on area treated, technique and patient factors.
Completely dissolvable and fully absorbed by the skin over time, enabling reversibility and natural degradation.
Monophasic, 100% cross-linked HA structure offers stable, homogenous gel for smooth and predictable injection.
Highly purified hyaluronic acid with low endotoxin and low residual BDDE levels, supporting safety and biocompatibility.
Contains lidocaine to reduce pain and improve comfort during injection.
Easy to inject and shape for experienced practitioners, allowing precise facial contouring.

Indications

Deep to very severe facial wrinkles and folds, including pronounced nasolabial folds and marionette lines.
Facial volumisation in areas such as cheeks, cheekbones, chin and jawline.
Restoration of age-related volume loss in mid-face and lower face.
Structural contouring and lifting for improved definition of cheekbones and facial angles.
Correction of deep lines in the mid and lower face where high-viscosity filler support is required.